Komori
General Meetings of Shareholders4974TAKARA BIO INC.Materials and Chemicals

(Amended) Notice of Convocation of an Extraordinary General Meeting of Shareholders

An extraordinary general meeting of shareholders will be held on 20 May 2026 to seek shareholder approval for a share consolidation and amendments to the Articles of Incorporation in connection with the tender offeror's acquisition of all shares and the delisting of the Company's shares.

Worth reading
54Recurring
Scored from 3 of 4 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
15332374
Reverse stock split of shares into 1 share
Wording
Conditional
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Extraordinary General Meeting of Shareholders
2026
May 20
Date and time11 days from this disclosure to the meeting
Matters for resolution2 items
  1. Consolidation of Shares

  2. Partial Amendments to the Articles of Incorporation

Shareholder Proposal

No

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingExtraordinary General Meeting of Shareholders
Date and time10:00 a.m. on Wednesday, 20 May 2026
Matters for resolutionProposal No. 1: Consolidation of Shares, Proposal No. 2: Partial Amendments to the Articles of Incorporation
Shareholder ProposalNo
Items this document does not state (2)
Director nomineePercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To convert the shares held by minority shareholders remaining after the tender offer into fractional shares, making the Company a wholly owned subsidiary of TAKARA HOLDINGS INC. and taking it private. The Company also expects benefits including reforms to its earnings structure, stronger business collaboration, new business development and reduced costs associated with maintaining its listing.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
(Amended) Notice of Convocation of an Extraordinary General Meeting of Shareholders | TAKARA BIO INC. (4974) timely disclosure | Komori